St. Jude Medical (STJ) Receives FDA Clearance for CPS Duo(TM) and CPS Courier(TM)
More News related to STJ
- St. Jude Medical and EP MedSystems Announce Final Exchange Ratio for Pending Acquisition
- St. Jude Medical Announces Second Quarter 2008 Earnings Conference Call
- St. Jude Medical and EP MedSystems Announce Cash/Stock Election Deadline and Expected Closing Date of Pending Acquisition
- St. Jude Medical (STJ) Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation
- St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
More News related to FDA
- Mylan (MYL) Receives Approval for Generic Zyvox
- APP Pharmaceuticals (APPX) Receives Final Approval for Generic Kytril
- Mylan (MYL) Receives Tentative Approval for Generic Zyvox
- Adolor (ADLR) Provides Update on Entereg(R) (alvimopan) OBD Program
- SkyePharma PLC (SKYE) Announces Positive Phase III Data on FlutiformTM
St. Jude Medical, Inc. (NYSE: STJ) today announced that the U.S. FDA and the European CE Mark have given approval of new delivery tools designed to give physicians greater control and precision when placing cardiac pacing leads in challenging heart anatomy.
The CPS Duo(TM) stylet and guidewire system and the CPS Courier(TM) guidewire received FDA clearance and CE Mark approvals, and the Mond(TM) stylet received FDA clearance.
St. Jude Medical, Inc. designs, manufactures, and distributes cardiovascular medical devices and implantable neurostimulation devices worldwide.
Related Categories
FDAStocks Mentioned
+0.47Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
